Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Celyad logo

Celyad

Recent Finacing

Hybrid

Recent Raise

$25M

Cardio3 BioSciences develops regenerative and protective cardiac therapies, including the C-Cure stem-cell treatment, C-Cath delivery catheter, protein therapeutics, and clinical collaborations across Europe and the US.

Founded 2007
Brabant Wallon, Belgium
51-100
Publicly Traded
celyad.com

Highlights

Focus Areas

Biotechnology
Medical Device
Oncology
Therapeutics

Recent Investors

European Commission logo
W

Financials

$29M

Total Raised

2

Funding rounds

2

Investors